Maven Securities’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,000
Closed -$3.47M 1062
2023
Q2
$3.47M Buy
+8,000
New +$4.5M 0.05% 178
2021
Q4
Sell
-4,836
Closed -$3.17M 822
2021
Q3
$3.17M Buy
+4,836
New +$4.13M 0.1% 149

Other funds holding AGL

Maven Securities's AGL Position: Q3 2023 in Review

Maven Securities sold out of Agilon Health (AGL) in Q3 2023, closing a stake of 8,000 shares — an estimated $3.47M sold.

Maven Securities first reported a position in AGL in Q3 2021 and held it in 2 quarters. The position peaked at $3.47M in Q2 2023. 177 funds tracked by Wall St. Rank hold AGL as of Q3 2023.

  • Maven Securities reported no remaining Agilon Health position as of Q3 2023 after selling out during the quarter.
  • Maven Securities sold 8,000 Agilon Health shares in Q3 2023, an estimated $3.47M.
  • Maven Securities first reported a position in Agilon Health in Q3 2021 and held it in 2 quarters.
  • Maven Securities's Agilon Health position peaked at $3.47M in Q2 2023.
  • 177 funds tracked by Wall St. Rank held Agilon Health as of Q3 2023.

Based on Maven Securities's 13F filing for Q3 2023, filed 13 Nov 2023.